Role of RNA-binding Proteins in Regulating Cell Adhesion and Progression of the Atherosclerotic Plaque and Plaque Erosion
- PMID: 39576410
- DOI: 10.1007/s11883-024-01250-2
Role of RNA-binding Proteins in Regulating Cell Adhesion and Progression of the Atherosclerotic Plaque and Plaque Erosion
Abstract
Purpose of review: RNA-binding proteins (RBPs) have emerged as crucial regulators of post-transcriptional processes, influencing the fate of RNA. This review delves into the biological functions of RBPs and their role in alternative splicing concerning atherosclerosis (AS), highlighting their participation in essential cellular processes. Our goal is to offer new insights for cardiovascular disease research and treatment.
Recent finding: Dysregulation of RBPs is associated with various human diseases, including autoimmune and neurological disorders. The role of RBPs in the pathogenesis of AS is progressively being elucidated, as they influence plaque formation and disease progression by regulating cell function and gene expression. RBPs play intricate biological roles in regulating pre-mRNA, including editing, splicing, stability and translation. Alternative splicing has been demonstrated to enhance biological complexity and diversity. Our findings indicate that alternative splicing is extensively involved in the pathogenesis of AS. The dysregulated expression of specific RBPs in AS is linked to the production of adhesion molecules and vascular endothelium damage. Further research on RBPs could pave the way for the development of novel therapeutic targets.
Keywords: Adhesion; Alternative splicing; Atherosclerosis; Inflammation; RNA-binding proteins.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing Interests: The authors declare no competing interests. Human and Animal Rights: This article does not contain any studies with human or animal subjects performed by any of the authors.
Similar articles
-
The Biological Mechanisms and Clinical Roles of RNA-Binding Proteins in Cardiovascular Diseases.Biomolecules. 2024 Aug 25;14(9):1056. doi: 10.3390/biom14091056. Biomolecules. 2024. PMID: 39334823 Free PMC article. Review.
-
Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT.Curr Cancer Drug Targets. 2020;20(9):654-665. doi: 10.2174/1568009620666200621153831. Curr Cancer Drug Targets. 2020. PMID: 32564755
-
Genome-wide analysis revealed the dysregulation of RNA binding protein-correlated alternative splicing events in myocardial ischemia reperfusion injury.BMC Med Genomics. 2023 Oct 19;16(1):251. doi: 10.1186/s12920-023-01706-5. BMC Med Genomics. 2023. PMID: 37858115 Free PMC article.
-
RNA-binding proteins potentially regulate alternative splicing of immune/inflammatory-associated genes during the progression of generalized pustular psoriasis.Arch Dermatol Res. 2024 Aug 19;316(8):538. doi: 10.1007/s00403-024-03283-8. Arch Dermatol Res. 2024. PMID: 39158708
-
RNA-binding proteins in vascular inflammation and atherosclerosis.Atherosclerosis. 2023 Jun;374:55-73. doi: 10.1016/j.atherosclerosis.2023.01.008. Epub 2023 Jan 17. Atherosclerosis. 2023. PMID: 36759270 Review.
References
-
- Zhang S, Liu Y, Cao Y et al. Targeting the Microenvironment of Vulnerable atherosclerotic plaques: an emerging diagnosis and therapy strategy for atherosclerosis. Adv Mater. 2022, 34(29). https://doi.org/10.1002/adma.202110660
-
- Tao Y, Zhang Q, Wang H, Yang X, Mu H. Alternative splicing and related RNA binding proteins in human health and disease. Signal Transduct Target Therapy. 2024, 9(1). https://doi.org/10.1038/s41392-024-01734-2
-
- Yao ZT, Yang YM, Sun MM, et al. New insights into the interplay between long non-coding RNAs and RNA‐binding proteins in cancer. Cancer Commun. 2022;42(2):117–40. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials